$119.69 0.7 0.5%
Last Trade - 16/04/21
| Market Cap | £17.72bn |
| Enterprise Value | £16.99bn |
| Revenue | £140.67bn |
| Position in Universe | 498th / 6850 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Sep | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 135,962 | 146,850 | 153,144 | 167,940 | 179,589 | 189,894 | 205,088 | 215,191 | +6.9% | ||
| -30.0 | +32.8 | +16.1 | -10.5 | +39.1 | +6.88 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.
| Last Annual | September 30th, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | March 16, 2001 |
| Public Since | December 16, 1993 |
| No. of Shareholders: | 2,385 |
| No. of Employees: | 22,000 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector), |
| Exchange | New York Stock Exchange |
| Shares in Issue | 204,706,150 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 1300 Morris Dr, CHESTERBROOK, 19087-5594, United States |
| Web | |
| Phone | +1 610 7277000 |
| Auditors | Ernst & Young LLP |
As of 16/04/21, shares in Amerisourcebergen are trading at $119.69, giving the company a market capitalisation of £17.72bn. This share price information is delayed by 15 minutes.
Shares in Amerisourcebergen are currently trading at $119.69 and the price has moved by 38.72% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Amerisourcebergen price has moved by -4.38% over the past year.
Of the analysts with advisory recommendations for Amerisourcebergen, there are there are currently 3 "buy" , 8 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Amerisourcebergen is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Amerisourcebergen is scheduled to issue upcoming financial results on the following dates:
The Amerisourcebergen dividend yield is 1.42% based on the trailing twelve month period.
Last year, Amerisourcebergen paid a total dividend of 1.7, and it currently has a trailing dividend yield of 1.42%. Looking ahead, Amerisourcebergen has not announced an ex-dividend date yet.
Amerisourcebergen has yet to annouce their ex-dividend date. The historic dividend yield on Amerisourcebergen shares is currently 1.42%.
To buy shares in Amerisourcebergen you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Amerisourcebergen are currently trading at $119.69, giving the company a market capitalisation of £17.72bn.
Here are the trading details for Amerisourcebergen:
Based on an overall assessment of its quality, value and momentum, Amerisourcebergen is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Amerisourcebergen are currently priced at $119.69. At that level they are trading at 6.78% discount to the analyst consensus target price of 0.00.
Analysts covering Amerisourcebergen currently have a consensus Earnings Per Share (EPS) forecast of 8.559 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Amerisourcebergen. Over the past six months, the relative strength of its shares against the market has been -1.17%. At the current price of $119.69, shares in Amerisourcebergen are trading at 15.9% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Amerisourcebergen PE ratio based on its reported earnings over the past 12 months is 17.73. The shares are currently trading at $119.69.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Amerisourcebergen's management team is headed by:
Here are the top five shareholders of Amerisourcebergen based on the size of their shareholding:
